183 related articles for article (PubMed ID: 11265229)
1. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
Thervet E
Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
[No Abstract] [Full Text] [Related]
2. Mycophenolate mofetil for the transplanted kidney?
Drug Ther Bull; 1997 May; 35(5):38-40. PubMed ID: 9282420
[TBL] [Abstract][Full Text] [Related]
3. Effects of mycophenolate mofetil on hematocrit after renal transplantation.
Chenhsu RY; Wu YM; Min DI; Zimmerman MB
Ann Pharmacother; 2002 Sep; 36(9):1479-80. PubMed ID: 12196073
[No Abstract] [Full Text] [Related]
4. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
Ettenger R; Cohen A; Nast C; Moulton L; Marik J; Gales B
Transplant Proc; 1997; 29(1-2):340-1. PubMed ID: 9123030
[No Abstract] [Full Text] [Related]
5. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
Rerolle JP; Szelag JC; Le Meur Y
Nephrol Dial Transplant; 2007 Feb; 22(2):671-2. PubMed ID: 16980323
[No Abstract] [Full Text] [Related]
6. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
[No Abstract] [Full Text] [Related]
7. Treatment of calcineurin inhibitor toxicity by dose reduction plus introduction of mycophenolate mofetil.
McKane W; Kanganas C; Preston R; Cairns T; Hakim N; Palmer A; Taube D
Transplant Proc; 2001; 33(1-2):1224-5. PubMed ID: 11267268
[No Abstract] [Full Text] [Related]
8. Relapse of atypical haemolytic uraemic syndrome after kidney transplantation: role of ATG and failure of mycophenolate mofetil as rescue therapy.
Davin JC; Gruppen M; Bouts AH; Groothoff JW; van Amstel SP; Surachno J; ten Berge IJ; Weening JJ
Nephrol Dial Transplant; 1999 Apr; 14(4):984-7. PubMed ID: 10328487
[No Abstract] [Full Text] [Related]
9. [Mycophenolate mofetil in comparison with other immunosuppressive drugs].
Schnülle P; van der Woude FJ
Internist (Berl); 1998 Aug; 39(8):879-86. PubMed ID: 9757398
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil in kidney transplantation.
Lui SL; Halloran PF
Curr Opin Nephrol Hypertens; 1996 Nov; 5(6):508-13. PubMed ID: 8978998
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil-associated enterocolitis.
Liu TC; Amorosino MS; Cerda S; Farraye FA
Gastrointest Endosc; 2006 Apr; 63(4):707-8, discussion 708. PubMed ID: 16564882
[No Abstract] [Full Text] [Related]
12. Mycophenolate mofetil in the prevention of rejection after kidney transplantation.
Kiehl MG
Transplantation; 2000 Apr; 69(8):1753-4. PubMed ID: 10836400
[No Abstract] [Full Text] [Related]
13. Mycophenolate mofetil for transplantation: new drug, old problems?
Gray DW
Lancet; 1995 Aug; 346(8972):390. PubMed ID: 7623565
[No Abstract] [Full Text] [Related]
14. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group.
Carl S; Wiesel M
Transplant Proc; 1997 Nov; 29(7):2932-5. PubMed ID: 9365619
[No Abstract] [Full Text] [Related]
15. Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients.
Keunecke C; Rothenpieler U; Zanker B; Schneeberger H; Illner WD; Theodorakis J; Stangl M; Land W
Transplant Proc; 2000 Feb; 32(1A Suppl):6S-8S. PubMed ID: 10686310
[No Abstract] [Full Text] [Related]
16. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J
Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567
[No Abstract] [Full Text] [Related]
17. Mycophenolate Mofetil Study.
Baltzan M; Shoker A; Baltzan R
Transplantation; 1997 Jan; 63(1):173-4. PubMed ID: 9000687
[No Abstract] [Full Text] [Related]
18. Mycophenolate approval provides new option for organ-rejection prevention.
Am J Health Syst Pharm; 1995 Oct; 52(19):2078. PubMed ID: 8535937
[No Abstract] [Full Text] [Related]
19. [Mycophenolate mofetil, a possible new immunosuppresant].
Weberová J; Voboril R; Semecký V
Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
[TBL] [Abstract][Full Text] [Related]
20. Is mycophenolate mofetil better than azathioprine in organ transplantation?
Ruggenenti P; Remuzzi G
Transplantation; 2006 Nov; 82(9):1242-3. PubMed ID: 17102781
[No Abstract] [Full Text] [Related]
[Next] [New Search]
